Effect of 18β-glycyrrhetinic acid on hyperglycemia and hyperlipidemia in type 2 diabetic rats

ZHAO Hai-yan,WANG Yan-fang,YANG Shao-juan
2013-01-01
Abstract:【Objective】To explore the effect of 18β-glycyrrhetinic acid on fasting blood glucose(FBG),lipids and sensitivity of insulin in type 2 diabetic rats.【Methods】Type 2 diabetes model was replicated by high-fathigh-sugar diet combined with lower dose STZ injection.All rats were randomly divided into five groups: control group(CON),control 18β-glycyrrhetinic acid treatment group(CGA),diabetes group(DM),DM+18β-glycyrrhetinic acid treatment group(DGA) and DM+glibenclamide treatment group(DGL).They were orally administered with 5% DMSO,18β-glycyrrhetinic acid[100mg/(kg·d)] and glibenclamide [600μg/(kg·d)] respectively.After 45 days of continuous medication,detect fasting blood glucose(FBG),lipids(TG,TC,LDL-C,HDL-C) and insulin level in serum of all rats.【Results】18β-glycyrrhetinic acid treatment significantly decreased the levels of FBG,TG,TC,LDL-C and homeostasis model assessment of insulin resistance(HOMA-IR) in diabetic rats,and also increased anti atherosclerosis index(AAI).【Conclusion】18β-glycyrrhetinic acid has hypoglycemic and hypolipidemic effects,and it can also ameliorate insulin resistance.
What problem does this paper attempt to address?